Prolinamide derivatives as NK3 antagonists

Details for Australian Patent Application No. 2008258665 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Wu, Xihan; Nettekoven, Matthias; Knust, Henner; Ratni, Hasane; Han, Bo

Agent Spruson & Ferguson

Pub. Number AU-B-2008258665 ( Modified Examination )

PCT Pub. Number WO2008/148689

Priority 07109781.0 07.06.07 EP

Filing date 29 May 2008

Wipo publication date 11 December 2008

Acceptance publication date 5 July 2012

International Classifications

C07D 207/16 Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/401 - Proline

A61P 25/16 Drugs for disorders of the nervous system

A61P 25/18 Drugs for disorders of the nervous system

C07D 401/06 Heterocyclic compounds containing two or more hetero rings

C07D 487/10 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/148689 Priority application(s): WO2008/148689

5 July 2012 Application Accepted

  Published as AU-B-2008258665 ( Modified Examination )

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008258675-Heatable humidifying device for use with tobacco products

2008258664-Prolinamide-tetrazole derivatives as NK3 receptor antagonists